Illumina, Chinese firm forge molecular Dx collaboration

04/22/2013 | GenomeWeb Daily News (free registration)

Illumina has entered a molecular diagnostics partnership with Kindstar Global, a provider of testing services in China. The deal calls for the companies to launch molecular diagnostic assays that use Illumina's TruSight sets for next-generation sequencing, NuPCR reagents for qPCR and the Infinium Dx CytoSNP-12 BeadChip test at Kindstar's laboratories.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX